Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Characterization of the hypnotic properties of oleamide.
Basile AS, Hanus L, Mendelson WB. Basile AS, et al. Among authors: hanus l. Neuroreport. 1999 Apr 6;10(5):947-51. doi: 10.1097/00001756-199904060-00010. Neuroreport. 1999. PMID: 10321465
A gas chromatographic-mass spectral assay for the quantitative determination of oleamide in biological fluids.
Hanus LO, Fales HM, Spande TF, Basile AS. Hanus LO, et al. Anal Biochem. 1999 May 15;270(1):159-66. doi: 10.1006/abio.1999.4083. Anal Biochem. 1999. PMID: 10328778
Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems.
Fedorova I, Hashimoto A, Fecik RA, Hedrick MP, Hanus LO, Boger DL, Rice KC, Basile AS. Fedorova I, et al. Among authors: hanus lo. J Pharmacol Exp Ther. 2001 Oct;299(1):332-42. J Pharmacol Exp Ther. 2001. PMID: 11561096
(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.
Fride E, Feigin C, Ponde DE, Breuer A, Hanus L, Arshavsky N, Mechoulam R. Fride E, et al. Among authors: hanus l. Eur J Pharmacol. 2004 Dec 15;506(2):179-88. doi: 10.1016/j.ejphar.2004.10.049. Eur J Pharmacol. 2004. PMID: 15588739
Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
Järbe TU, Hiltunen AJ, Mathis DA, Hanŭs L, Breuer A, Mechoulam R. Järbe TU, et al. Among authors: hanus l. J Pharmacol Exp Ther. 1993 Feb;264(2):561-9. J Pharmacol Exp Ther. 1993. PMID: 8382275
Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides.
Barg J, Fride E, Hanus L, Levy R, Matus-Leibovitch N, Heldman E, Bayewitch M, Mechoulam R, Vogel Z. Barg J, et al. Among authors: hanus l. Eur J Pharmacol. 1995 Dec 12;287(2):145-52. doi: 10.1016/0014-2999(95)00487-4. Eur J Pharmacol. 1995. PMID: 8749028
New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.
Ben-Shabat S, Hanus LO, Katzavian G, Gallily R. Ben-Shabat S, et al. J Med Chem. 2006 Feb 9;49(3):1113-7. doi: 10.1021/jm050709m. J Med Chem. 2006. PMID: 16451075
HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.
Haj CG, Sumariwalla PF, Hanuš L, Kogan NM, Yektin Z, Mechoulam R, Feldmann M, Gallily R. Haj CG, et al. Among authors: hanus l. J Pharmacol Exp Ther. 2015 Oct;355(1):66-75. doi: 10.1124/jpet.115.226100. Epub 2015 Aug 13. J Pharmacol Exp Ther. 2015. PMID: 26272937 Free PMC article.
Endogenous cannabinoid ligands--chemical and biological studies.
Mechoulam R, Ben Shabat S, Hanus L, Fride E, Vogel Z, Bayewitch M, Sulcova AE. Mechoulam R, et al. Among authors: hanus l. J Lipid Mediat Cell Signal. 1996 Sep;14(1-3):45-9. doi: 10.1016/0929-7855(96)01507-6. J Lipid Mediat Cell Signal. 1996. PMID: 8906544 Review.
Search for endogenous ligands of the cannabinoid receptor.
Mechoulam R, Hanus L, Martin BR. Mechoulam R, et al. Among authors: hanus l. Biochem Pharmacol. 1994 Oct 18;48(8):1537-44. doi: 10.1016/0006-2952(94)90197-x. Biochem Pharmacol. 1994. PMID: 7980618 Review. No abstract available.
83 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page